__timestamp | Eli Lilly and Company | Xencor, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 19615600000 | 9520000 |
Thursday, January 1, 2015 | 19958700000 | 27762000 |
Friday, January 1, 2016 | 21222100000 | 87520000 |
Sunday, January 1, 2017 | 22871300000 | 35711000 |
Monday, January 1, 2018 | 21493300000 | 40603000 |
Tuesday, January 1, 2019 | 22319500000 | 156700000 |
Wednesday, January 1, 2020 | 24539800000 | 122694000 |
Friday, January 1, 2021 | 28318400000 | 275111000 |
Saturday, January 1, 2022 | 28541400000 | 164579000 |
Sunday, January 1, 2023 | 34124100000 | 168338000 |
Monday, January 1, 2024 | 45042700000 |
Igniting the spark of knowledge
In the ever-evolving landscape of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Eli Lilly and Company has demonstrated a robust upward trajectory, with its revenue surging by approximately 74% from 2014 to 2023. This growth underscores Eli Lilly's strategic prowess in the pharmaceutical industry, as it continues to innovate and expand its market reach.
Conversely, Xencor, Inc., a smaller player in the biotech arena, has shown a more modest revenue increase of around 1,670% over the same period. While its absolute numbers are dwarfed by Eli Lilly, Xencor's growth rate highlights its potential and the increasing interest in its specialized offerings.
This comparison not only showcases the diverse strategies of these companies but also reflects broader trends in the biotech sector, where innovation and adaptability are key to thriving.
Eli Lilly and Company and BeiGene, Ltd.: A Comprehensive Revenue Analysis
Revenue Showdown: Eli Lilly and Company vs Incyte Corporation
Breaking Down Revenue Trends: Eli Lilly and Company vs Lantheus Holdings, Inc.
Eli Lilly and Company and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
Eli Lilly and Company vs PTC Therapeutics, Inc.: Annual Revenue Growth Compared
Revenue Insights: Eli Lilly and Company and HUTCHMED (China) Limited Performance Compared
Eli Lilly and Company vs Evotec SE: Annual Revenue Growth Compared
Zoetis Inc. vs Xencor, Inc.: Annual Revenue Growth Compared
GSK plc vs Xencor, Inc.: Annual Revenue Growth Compared
Revenue Showdown: BeiGene, Ltd. vs Xencor, Inc.
Comparing Revenue Performance: Lantheus Holdings, Inc. or Xencor, Inc.?
Revenue Showdown: Vericel Corporation vs Xencor, Inc.